Literature DB >> 30686847

Using an Anchor to Improve Linear Predictions with Application to Predicting Disease Progression.

Alex Karanevich1, Jianghua He1, Byron J Gajewski1.   

Abstract

Linear models are some of the most straightforward and commonly used modelling approaches. Consider modelling approximately monotonic response data arising from a time-related process. If one has knowledge as to when the process began or ended, then one may be able to leverage additional assumed data to reduce prediction error. This assumed data, referred to as the "anchor," is treated as an additional data-point generated at either the beginning or end of the process. The response value of the anchor is equal to an intelligently selected value of the response (such as the upper bound, lower bound, or 99th percentile of the response, as appropriate). The anchor reduces the variance of prediction at the cost of a possible increase in prediction bias, resulting in a potentially reduced overall mean-square prediction error. This can be extremely effective when few individual data-points are available, allowing one to make linear predictions using as little as a single observed data-point. We develop the mathematics showing the conditions under which an anchor can improve predictions, and also demonstrate using this approach to reduce prediction error when modelling the disease progression of patients with amyotrophic lateral sclerosis.

Entities:  

Keywords:  Linear models; amyotrophic lateral sclerosis; anchor; biased regression; ordinary least squares

Year:  2018        PMID: 30686847      PMCID: PMC6345390          DOI: 10.15446/rce.v41n2.68535

Source DB:  PubMed          Journal:  Rev Colomb Estad        ISSN: 0120-1751


  6 in total

1.  Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis.

Authors:  C Armon; M C Graves; D Moses; D K Forté; L Sepulveda; S M Darby; R A Smith
Journal:  Muscle Nerve       Date:  2000-06       Impact factor: 3.217

2.  The logistic transform for bounded outcome scores.

Authors:  Emmanuel Lesaffre; Dimitris Rizopoulos; Roula Tsonaka
Journal:  Biostatistics       Date:  2006-04-05       Impact factor: 5.899

3.  The PRO-ACT database: design, initial analyses, and predictive features.

Authors:  Nazem Atassi; James Berry; Amy Shui; Neta Zach; Alexander Sherman; Ervin Sinani; Jason Walker; Igor Katsovskiy; David Schoenfeld; Merit Cudkowicz; Melanie Leitner
Journal:  Neurology       Date:  2014-10-08       Impact factor: 9.910

4.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

5.  Disease progression in amyotrophic lateral sclerosis: predictors of survival.

Authors:  T Magnus; M Beck; R Giess; I Puls; M Naumann; K V Toyka
Journal:  Muscle Nerve       Date:  2002-05       Impact factor: 3.217

6.  Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.

Authors:  Alex G Karanevich; Jeffrey M Statland; Byron J Gajewski; Jianghua He
Journal:  BMC Med Res Methodol       Date:  2018-02-06       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.